Clinical Trial Update: Collection of Sputum and Labeling for Lung Cancer

View source ↗

Summary

A clinical trial sponsored by bioAffinity Technologies Inc. is currently recruiting to collect sputum and label samples for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: bioAffinity Technologies Inc. | Conditions: Lung Cancer | Status: RECRUITING